[go: up one dir, main page]

ES2421709T3 - Uso de veneno de abeja para tratar la enfermedad de Parkinson - Google Patents

Uso de veneno de abeja para tratar la enfermedad de Parkinson

Info

Publication number
ES2421709T3
ES2421709T3 ES08827349T ES08827349T ES2421709T3 ES 2421709 T3 ES2421709 T3 ES 2421709T3 ES 08827349 T ES08827349 T ES 08827349T ES 08827349 T ES08827349 T ES 08827349T ES 2421709 T3 ES2421709 T3 ES 2421709T3
Authority
ES
Spain
Prior art keywords
disease
bee venom
treat parkinson
kinson
micrograms
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES08827349T
Other languages
English (en)
Inventor
Andreas Hartmann
Anne-Marie Bonnet
Michael Schuepbach
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Assistance Publique Hopitaux de Paris APHP
Original Assignee
Assistance Publique Hopitaux de Paris APHP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0704754A external-priority patent/FR2918282B1/fr
Priority claimed from FR0706697A external-priority patent/FR2918281B1/fr
Application filed by Assistance Publique Hopitaux de Paris APHP filed Critical Assistance Publique Hopitaux de Paris APHP
Application granted granted Critical
Publication of ES2421709T3 publication Critical patent/ES2421709T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/10—Peptides having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/63—Arthropods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/858—Proteins from animals other than mammals or birds insects; venom

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Insects & Arthropods (AREA)
  • Psychology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Utilización de veneno de abeja, en una cantidad comprendida entre 33 y 330 microgramos incluidos,para la fabricación de una dosis unitaria para inyección subcutánea, una cada seis semanas, de un medicamentopara aliviar los síntomas y/o restaurar y/o proteger las neuronas de pacientes afectados por la enfermedad de Par-kinson
ES08827349T 2007-07-02 2008-07-01 Uso de veneno de abeja para tratar la enfermedad de Parkinson Active ES2421709T3 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0704754A FR2918282B1 (fr) 2007-07-02 2007-07-02 Medicament pour le traitement de la maladie de parkinson
FR0706697A FR2918281B1 (fr) 2007-09-25 2007-09-25 Medicament pour le traitement de la maladie de parkinson.
PCT/FR2008/000937 WO2009022067A2 (fr) 2007-07-02 2008-07-01 Medicament pour traiter la maladie de parkinson

Publications (1)

Publication Number Publication Date
ES2421709T3 true ES2421709T3 (es) 2013-09-05

Family

ID=40282369

Family Applications (1)

Application Number Title Priority Date Filing Date
ES08827349T Active ES2421709T3 (es) 2007-07-02 2008-07-01 Uso de veneno de abeja para tratar la enfermedad de Parkinson

Country Status (7)

Country Link
US (1) US8232249B2 (es)
EP (1) EP2173366B1 (es)
JP (1) JP5517925B2 (es)
DK (1) DK2173366T3 (es)
ES (1) ES2421709T3 (es)
PT (1) PT2173366E (es)
WO (1) WO2009022067A2 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2918282B1 (fr) * 2007-07-02 2009-10-02 Assistance Publique Hopitaux P Medicament pour le traitement de la maladie de parkinson
KR101070600B1 (ko) * 2009-05-22 2011-10-06 주식회사 휴온스 봉독으로부터 분리된 봉독 정제물을 유효성분으로 포함하는 퇴행성 뇌질환의 예방 및 치료를 위한 조성물
WO2013083574A1 (en) 2011-12-05 2013-06-13 Key Neurosciences Sas Composition for treating parkinson's disease.
US8596814B2 (en) * 2012-02-14 2013-12-03 Cheng-Sheng Yang LED light tube and a circuit module for the same
US10232048B1 (en) 2014-11-18 2019-03-19 Divine Api-Logics, LLC Apitherapy method and composition
KR102085570B1 (ko) * 2017-08-14 2020-03-06 한국 한의학 연구원 아파민을 유효성분으로 포함하는 통풍성 관절염의 예방 또는 치료용 조성물
JP7249433B2 (ja) * 2019-03-28 2023-03-30 イニスト エスティー カンパニー リミテッド 蜂毒抽出物を有効成分として含有する神経炎症疾患の予防または治療用組成物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3989188B2 (ja) * 2001-04-27 2007-10-10 クリストファー・エム・キム 蜂針を用いない蜂毒療法
FR2918282B1 (fr) * 2007-07-02 2009-10-02 Assistance Publique Hopitaux P Medicament pour le traitement de la maladie de parkinson

Also Published As

Publication number Publication date
US8232249B2 (en) 2012-07-31
EP2173366A2 (fr) 2010-04-14
US20110059184A1 (en) 2011-03-10
JP5517925B2 (ja) 2014-06-11
DK2173366T3 (da) 2013-07-22
WO2009022067A2 (fr) 2009-02-19
WO2009022067A8 (fr) 2009-04-09
EP2173366B1 (fr) 2013-05-22
WO2009022067A3 (fr) 2009-12-17
JP2010531861A (ja) 2010-09-30
PT2173366E (pt) 2013-07-29

Similar Documents

Publication Publication Date Title
AR109170A2 (es) Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente
ES2421709T3 (es) Uso de veneno de abeja para tratar la enfermedad de Parkinson
CY1124135T1 (el) Δοσολογικα σχηματα για την αγωγη της νοσου ρομρε
PE20170302A1 (es) Uso de pridopidina en dosis altas para el tratamiento de enfermedad de huntington
AR054249A1 (es) Tratamiento de enfermedades del tejido conectivo de la piel
NI201100147A (es) Métodos para tratar infartos agudos de miocardio y trastornos relacionados.
AR077896A1 (es) Terapia de baja frecuencia con acetato de glatiramer. uso. acetato de glatiramer.
ES2422286T3 (es) Uso de apamina para tratar la enfermedad de Parkinson
CR9994A (es) Vacuna terapéutica
EA202091999A3 (ru) Применение ингибиторов dpp iv
PE20070333A1 (es) Composicion farmaceutica que comprende agomelatina para el tratamiento de transtornos del sueno en pacientes deprimidos
AR061122A1 (es) Regimen de cladribina para tratar la escleorosis multiple
AR070026A1 (es) Conjunto de elementos para la dosificacion de 1-amino-alquilciclohexanos, tal como neramexano, y tratamiento de diversas enfermedades incluyendo el tinnitus
AR109103A1 (es) Tratamiento de la enfermedad de fabry en pacientes no tratados y tratados previamente con ert
BR112014015482A2 (pt) compostos carbamato de fenila para uso no alívio ou tratamento de dor e dor neuropática
UY33277A (es) Compuestos de anillo espiro-tetraciclico como moduladores de beta-secretasa y métodos de uso
CL2011001927A1 (es) Uso de una composicion farmaceutica de liberacion sostenida, que comprende como ingrediente activo a 4-aminopiridina, que sirve para preparar un medicamento util para el tratamiento de la esclerosis multiple, en dos dosis de 10 miligramos diarias, que permite recuperar la marcha de un paciente afectado.
AR065392A1 (es) Metodos para el tratamiento por inhalacion de una enfermedad o estado respiratorio
MX2007010752A (es) Usos oftalmicos de moduladores de receptor s1p.
CO6270217A2 (es) Formulaciones galenicas de alisquireno y valsartan
CO6640324A2 (es) Uso de metformina en combinación con un activador de glucoquinasa y composiciones que comprenden metformina y un activador de glucoquinasa
AR080096A1 (es) Tratamiento combinado de cancer de pancreas con gemcitabina y masitinib
BRPI0418157A (pt) terapêutica de tumores alogênicos
AR088204A1 (es) Medicamentos para el tratamiento de la rinitis alergica que comprenden un antagonista de pgd2 y un antagonista de histamina
AR072951A1 (es) Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre